Literature DB >> 27611762

The biology of glucagon and the consequences of hyperglucagonemia.

Nicolai J Wewer Albrechtsen1,2, Rune E Kuhre1,2, Jens Pedersen1,2, Filip K Knop1,2,3, Jens J Holst1,2.   

Abstract

The proglucagon-derived peptide hormone, glucagon, comprises 29 amino acids. Its secretion from the pancreatic α cells is regulated by several factors. Glucagon increases blood glucose levels through gluconeogenesis and glycogenolysis. Elevated plasma concentrations of glucagon, hyperglucagonemia, may contribute to diabetes. However, hyperglucagonemia is also observed in other clinical conditions than diabetes, including nonalcoholic fatty liver disease, glucagon-producing tumors and after gastric bypass surgery. Here, we review the current literature on hyperglucagonemia in disease with a particular focus on diabetes, and finally speculate that the primary physiological importance of glucagon may not reside in glucose homeostasis but in regulation of amino acid metabolism exerted via a hitherto unrecognized hepato-pancreatic feedback loop.

Entities:  

Keywords:  diabetes; glucagon; hyperglucagonemia; proglucagon

Mesh:

Substances:

Year:  2016        PMID: 27611762     DOI: 10.2217/bmm-2016-0090

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  31 in total

1.  Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte.

Authors:  Kirk M Habegger
Journal:  Diabetes       Date:  2022-09-01       Impact factor: 9.337

Review 2.  Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.

Authors:  Robert L Rodgers
Journal:  Physiol Rep       Date:  2022-05

3.  DR10601, a novel recombinant long-acting dual glucagon-like peptide-1 and glucagon receptor agonist for the treatment of obesity and type 2 diabetes mellitus.

Authors:  W Wang; X Wen; W Duan; X Wang; Y Chen; J Dong; Z Yang; J Fang; Z Zhou; G Yao; Y Fang; Y Huang
Journal:  J Endocrinol Invest       Date:  2019-11-30       Impact factor: 4.256

4.  Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.

Authors:  Katrine D Galsgaard; Marie Winther-Sørensen; Cathrine Ørskov; Hannelouise Kissow; Steen S Poulsen; Hendrik Vilstrup; Cornelia Prehn; Jerzy Adamski; Sara L Jepsen; Bolette Hartmann; Jenna Hunt; Maureen J Charron; Jens Pedersen; Nicolai J Wewer Albrechtsen; Jens J Holst
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-10-03       Impact factor: 4.310

5.  Increased alpha and beta cell mass during mouse pregnancy is not dependent on transdifferentiation.

Authors:  Sandra K Szlapinski; Jamie Bennett; Brenda J Strutt; David J Hill
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-24

6.  O-linked N-Acetylglucosamine Transferase (OGT) regulates pancreatic α-cell function in mice.

Authors:  Ahmad Essawy; Seokwon Jo; Megan Beetch; Amber Lockridge; Eric Gustafson; Emilyn U Alejandro
Journal:  J Biol Chem       Date:  2021-01-15       Impact factor: 5.157

7.  Hyperglucagonemia in Pediatric Adiposity Associates With Cardiometabolic Risk Factors but Not Hyperglycemia.

Authors:  Sara E Stinson; Anna E Jonsson; Ierai Fernández de Retana Alzola; Morten A V Lund; Christine Frithioff-Bøjsøe; Louise Aas Holm; Cilius E Fonvig; Oluf Pedersen; Lars Ängquist; Thorkild I A Sørensen; Jens J Holst; Michael Christiansen; Jens-Christian Holm; Bolette Hartmann; Torben Hansen
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

8.  Glucagon's Metabolic Action in Health and Disease.

Authors:  Anja Zeigerer; Revathi Sekar; Maximilian Kleinert; Shelly Nason; Kirk M Habegger; Timo D Müller
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090

9.  Mutational Landscape of the Proglucagon-Derived Peptides.

Authors:  Peter Lindquist; Jakob S Madsen; Hans Bräuner-Osborne; Mette M Rosenkilde; Alexander S Hauser
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

10.  Impact of glucagon response on early postprandial glucose excursions irrespective of residual β-cell function in type 1 diabetes: A cross-sectional study using a mixed meal tolerance test.

Authors:  Ayako Ito; Ichiro Horie; Masaki Miwa; Ayaka Sako; Tetsuro Niri; Yomi Nakashima; Riyoko Shigeno; Ai Haraguchi; Shoko Natsuda; Satoru Akazawa; Akie Kamada; Atsushi Kawakami; Norio Abiru
Journal:  J Diabetes Investig       Date:  2021-01-22       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.